Consensus Medline Inc.

Stocks

MDLN

US58507V1070

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 22:42:24 06/11/2026 +03			5-day change	1st Jan Change
39.73 ^USD	-0.08%		+23.63%	-5.45%

11-05	UBS Adjusts Price Target on Medline to $49 From $43, Maintains Buy Rating	MT
11-04	Medline Shares Rise After Q3 Beat	MT

Evolution of the Average Target: Medline Inc.

Evolution of the Target Price: Medline Inc.

Changes in Analyst Recommendations: Medline Inc.

127307617ce6fddc1778ca228f78a39.vqSmo61s_vTOmI4clSDcDpCtcc3dPvn1CdKAGwfEHJ4.8sHV05xfkr-RzcZm4me2P93_KbuoTpeqX4HhTnW9KMjO9vnz7h6XwqPy_Q~492dccfde05fff980a87a7d5d46f1f61

Analysts' recommendations: Medline Inc.

11-05	UBS Adjusts Price Target on Medline to $49 From $43, Maintains Buy Rating	MT
09-25	UBS Cuts Medline Price Target to $43 From $45, Maintains Buy Rating	MT
08-14	Tigress Financial Adjusts Medline Price Target to $55 From $62, Maintains Buy Rating	MT
08-11	Tigress Financial Adjusts Medline Price Target to $55 From $62, Maintains Buy Rating	MT
08-06	RBC Capital Adjusts Medline Price Target to $46 From $53, Maintains Outperform Rating	MT
08-06	BofA Securities Adjusts Price Target on Medline to $46 From $53	MT
08-06	Deutsche Bank Adjusts Medline Price Target to $37 From $42, Maintains Hold Rating	MT
08-06	Truist Securities Adjusts Price Target on Medline to $47 From $56, Maintains Buy Rating	MT
06-03	Analyst recommendations: Chipotle, Fedex, Yum! Brands, Dollar General, Humana…
05-14	Tigress Financial Adjusts Price Target on Medline to $62 From $60, Maintains Buy Rating	MT
05-07	Deutsche Bank Adjusts Medline Price Target to $42 From $48, Maintains Hold Rating	MT
03-09	Tigress Financial Raises Price Target on Medline to $60 From $55, Keeps Buy Rating	MT
03-02	Truist Securities Raises Price Target on Medline to $56 From $52, Maintains Buy Rating	MT
03-02	Global markets live: Amazon, AWS, Lufthansa, Saudi Aramco, Standard Chartered…
03-02	Analyst recommendations: Applovin, Crowdstrike, Netflix, Blackstone, Roblox…
02-26	UBS Adjusts Price Target on Medline to $57 From $48, Maintains Buy Rating	MT
02-26	Deutsche Bank Raises Price Target on Medline to $48 From $40, Keeps Hold Rating	MT
02-26	RBC Raises Price Target on Medline to $53 From $47, Keeps Outperform Rating	MT
02-26	Analyst recommendations: Spotify, Gartner, Godaddy, Medline, Moderna…
02-05	Tigress Initiates Medline at Buy With $55 Price Target	MT
02-03	TD Cowen Initiates Coverage on Medline With Buy Rating, $46 Price Target	MT
01-12	Medline Poised to Leverage Business Model to Outsized Performance, RBC Says	MT
01-12	Medline Poised to Sustain High-Single Digit Organic Growth, BofA Says	MT
01-12	Morgan Stanley Initiates Coverage on Medline With Overweight Rating, $48 Price Target	MT
01-12	Leerink Partners Initiates Coverage on Medline With Outperform Rating, $48 Price Target	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	MEDLINE INC.					+11.44%
	ABBOTT LABORATORIES					+4.33%
	STRYKER CORPORATION					+1.61%
	MEDTRONIC PLC					-0.21%
	ESSILORLUXOTTICA					+12.48%
	CENCORA, INC.					+9.42%
	BECTON, DICKINSON AND COMPANY					-8.42%
	IDEXX LABORATORIES, INC.					+5.68%
	HOYA CORPORATION					+27.1%
	ALCON INC.					+16.86%
	Average					+8.03%
	Weighted average by Cap.					+5.98%